[go: up one dir, main page]

SE0402084D0 - Method and composition for long-term glycemic control - Google Patents

Method and composition for long-term glycemic control

Info

Publication number
SE0402084D0
SE0402084D0 SE0402084A SE0402084A SE0402084D0 SE 0402084 D0 SE0402084 D0 SE 0402084D0 SE 0402084 A SE0402084 A SE 0402084A SE 0402084 A SE0402084 A SE 0402084A SE 0402084 D0 SE0402084 D0 SE 0402084D0
Authority
SE
Sweden
Prior art keywords
hba1c value
composition
long
value
lowering
Prior art date
Application number
SE0402084A
Other languages
English (en)
Inventor
Mats Lake
Ulf Smith
Original Assignee
Metcon Medicin Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metcon Medicin Ab filed Critical Metcon Medicin Ab
Priority to SE0402084A priority Critical patent/SE0402084D0/sv
Publication of SE0402084D0 publication Critical patent/SE0402084D0/sv
Priority to PCT/SE2005/001233 priority patent/WO2006022585A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/718Starch or degraded starch, e.g. amylose, amylopectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE0402084A 2004-08-26 2004-08-26 Method and composition for long-term glycemic control SE0402084D0 (sv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0402084A SE0402084D0 (sv) 2004-08-26 2004-08-26 Method and composition for long-term glycemic control
PCT/SE2005/001233 WO2006022585A1 (en) 2004-08-26 2005-08-24 Composition and method for long-term glycemic control

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0402084A SE0402084D0 (sv) 2004-08-26 2004-08-26 Method and composition for long-term glycemic control

Publications (1)

Publication Number Publication Date
SE0402084D0 true SE0402084D0 (sv) 2004-08-26

Family

ID=33029189

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0402084A SE0402084D0 (sv) 2004-08-26 2004-08-26 Method and composition for long-term glycemic control

Country Status (2)

Country Link
SE (1) SE0402084D0 (sv)
WO (1) WO2006022585A1 (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563066B2 (en) 2007-12-17 2013-10-22 New World Pharmaceuticals, Llc Sustained release of nutrients in vivo
US20170202789A1 (en) 2014-07-16 2017-07-20 New World Pharmaceuticals, Llc Methods and related compositions for improved drug bioavailability and disease treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60121981D1 (de) * 2000-10-25 2006-09-14 Metcon Medicin Ab Zusammensetzung zur behandlung von störungen des blutzuckerstoffwechsels und verfahren zu ihrer herstellung
SE0200539D0 (sv) * 2002-02-25 2002-02-25 Metcon Medicin Ab Granulation process and starch granulate

Also Published As

Publication number Publication date
WO2006022585A1 (en) 2006-03-02

Similar Documents

Publication Publication Date Title
MX2007012102A (es) Control superior de glucosa en la sangre en tratamiento de diabetes.
NO20082377L (no) Anordning for automatisk regulering av glukosekonsentrasjonen i blodet hos en diabetespasient
EP2594564A3 (en) 2-acylaminopropanol-type glucosylceramide synthase inhibitors
NZ608829A (en) Pharmaceutical composition comprising an sglt2-inhibitor, methods for treating and uses thereof
WO2011112822A8 (en) Implantable therapeutic device and methods of making
MX2009009416A (es) Derivados de bencimidazol y sus metodos de uso.
WO2006044531A3 (en) Antisense modulation of ptp1b expression
MXPA05006994A (es) Composiciones y metodos para la prevencion y el control de hipoglucemia inducida por insulina.
MX2009009417A (es) Piperidinil-piperidina y piperazinil-piperidina para uso en el tratamiento de diabetes o dolor.
NO20053041L (no) Behandling av diabetes.
Schnell et al. Impaired glucose tolerance, diabetes, and cardiovascular disease
WO2009026517A3 (en) Therapy for complications of diabetes
WO2005113016A3 (en) Modulation of glucose-6-phosphatase translocase expression
SE0402084D0 (sv) Method and composition for long-term glycemic control
Kurien et al. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide
UA93581C2 (ru) средство, которое содержит G-CSF, для профилактики и лечения диабетической периферической невропатии
PL2029231T3 (pl) Zastosowanie alfa-laktalbuminy w regulacji glikemii
WO2006004696A3 (en) Compositions and methods for the prevention and control of insulin-induced hypoglycemia
Ligtenberg et al. Effect of glibenclamide on insulin release at moderate and high blood glucose levels in normal man
WO2012047628A3 (en) Methods of managing blood sugar levels and compositions related thereto
WO2007076505A3 (en) Transferrin and transferrin-based compositions for diabetes treatment
SG159462A1 (en) Multi-herbal medicinal composite for treating the metabolic syndrome and preparation method thereof
Triplitt Cardiac risk factors and hypoglycemia in an elderly patient: how good is good enough?
Ceriello et al. The evolving frontier of diabetes therapy: the renaissance of glycemology
WO2011152658A3 (en) Pharmaceutical composition comprising piperazine dithioctate and glimepiride